Ligand validation:3EL2

ATP: ADENOSINE-5'-TRIPHOSPHATE

ATP is a Ligand Of Interest in 3EL2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3EL2_ATP_A_800	83%	38%	0.107	0.967	0.95	1.48	-	5	1	0	100%	1
2HF4_ATP_A_800	97%	57%	0.063	0.981	0.72	0.91	-	2	0	0	100%	1
3CIP_ATP_A_401	97%	41%	0.08	0.993	0.9	1.38	1	4	0	0	100%	1
3A5N_ATP_C_376	96%	26%	0.073	0.985	1.26	1.7	2	6	0	0	100%	1
3CI5_ATP_A_401	96%	38%	0.084	0.994	0.92	1.5	1	5	0	0	100%	1
3MN9_ATP_A_800	95%	32%	0.09	0.994	1.03	1.63	2	6	0	0	100%	1
3MHY_ATP_C_113	100%	53%	0.034	0.992	0.86	0.94	-	2	0	0	100%	1
4CBU_ATP_A_1369	100%	50%	0.045	0.997	0.68	1.25	-	3	0	0	100%	1
5LPA_ATP_A_301	100%	51%	0.049	0.995	0.79	1.11	-	3	0	0	100%	1
3GAI_ATP_A_999	100%	43%	0.048	0.993	0.93	1.26	1	4	0	0	100%	1
3NCQ_ATP_C_200	100%	38%	0.04	0.984	1.04	1.4	-	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.